Humanin's Value for Early Diagnosis and Short-term Prognosis in Patients With AKI After Heart Transplantation

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to explore the value of Humanin for early diagnosis and short-term prognosis of AKI patients after heart transplantation. The main question it aims to answer are:whether Humanin can be a novel marker for predicting AKI after heart transplantation Researchers will compare the Humanin concentration in patients with AKI did not occur after heart transplantation to see if Humanin can be a novel marker for predicting AKI after heart transplantation

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Guangdong Provincial People's Hospital performs heart transplantation;Adult patients ≥ 18 years of age, male or female;Basic renal function is normal before surgery;The patient's baseline medical records are complete, including basic heart diseases, comorbidities, hemoglobin, renal function, urine protein quantification, serum albumin, lactic acid, C-reactive protein, heart transplantation operation time, preoperative and postoperative medication and blood pressure, blood transfusion history, ICU length of stay, cardiac ultrasound (including LVEF), etc;

Locations
Other Locations
China
Guangdong Provincial People's Hospital
RECRUITING
Guangdong
Contact Information
Primary
zhilian li, doctor
lizhilian@gdph.org.cn
13580560903
Time Frame
Start Date: 2022-07-01
Estimated Completion Date: 2024-06
Participants
Target number of participants: 60
Treatments
Patients with AKI after heart transplantation
AKI occurs in patients after heart transplantation
Patients did not develop AKI after heart transplantation
Patients who do not develop AKI after heart transplantation
Related Therapeutic Areas
Sponsors
Leads: Li zhilian

This content was sourced from clinicaltrials.gov